176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.53%
Negative revenue growth while AMD stands at 8.23%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
8.99%
Gross profit growth at 75-90% of AMD's 11.37%. Bill Ackman would demand operational improvements to match competitor gains.
20.44%
EBIT growth below 50% of AMD's 988.46%. Michael Burry would suspect deeper competitive or cost structure issues.
20.44%
Operating income growth under 50% of AMD's 1220.00%. Michael Burry would be concerned about deeper cost or sales issues.
3.66%
Net income growth under 50% of AMD's 1007.41%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.85%
EPS growth under 50% of AMD's 800.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.85%
Diluted EPS growth under 50% of AMD's 800.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.48%
Share reduction while AMD is at 3.04%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.68%
Reduced diluted shares while AMD is at 0.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.48%
Dividend growth of 0.48% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-69.13%
Negative OCF growth while AMD is at 11.08%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-116.49%
Negative FCF growth while AMD is at 16.93%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
393.83%
10Y revenue/share CAGR above 1.5x AMD's 91.19%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
118.57%
5Y revenue/share CAGR at 75-90% of AMD's 139.39%. Bill Ackman would encourage strategies to match competitor’s pace.
93.37%
3Y revenue/share CAGR above 1.5x AMD's 51.07%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
116.55%
10Y OCF/share CAGR under 50% of AMD's 865.50%. Michael Burry would worry about a persistent underperformance in cash creation.
-67.09%
Negative 5Y OCF/share CAGR while AMD is at 202.36%. Joel Greenblatt would question the firm’s operational model or cost structure.
-76.51%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
226.07%
Net income/share CAGR 1.25-1.5x AMD's 200.00%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-21.17%
Negative 5Y net income/share CAGR while AMD is 100.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-25.67%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
353.20%
Below 50% of AMD's 5999.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
226.49%
Below 50% of AMD's 3233.74%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
87.08%
Below 50% of AMD's 937.09%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
15.64%
Dividend/share CAGR of 15.64% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
1.31%
3Y dividend/share CAGR of 1.31% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-7.69%
Firm’s AR is declining while AMD shows 17.18%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
14.53%
We show growth while AMD is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-6.87%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-10.06%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-6.35%
We’re deleveraging while AMD stands at 0.07%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
6.63%
R&D growth drastically higher vs. AMD's 4.44%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
6.59%
SG&A growth well above AMD's 5.30%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.